BridgeMD
Tests treatment safety and results for Spinal Muscular Atrophy (SMA)
Official title Safety and Tolerability of Low Motoneuron Stimulation Via Transcranial Magnetic Stimulation in Spinal Muscular Atrophy
ClinicalTrials.gov ID: NCT06977269
What this study is testing
- What it's testing
- There is a general physiological rule that any organ or system needs some minimal amount of activity to prevent its atrophy or degeneration. Although the relevance of that rule to exercises in neuromuscular patients and for SMA in particular is not definitely proven, clinical observations seem to support this assumption.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 and older
You may be able to join if
- Subject has a diagnosis of 5q-autosomal recessive SMA confirmed by DNA test.
- Informed consent.
- A minimum score of 1 for Entry Item "A" of the Revised Upper Limb Module (RULM) scale for SMA: "Can use hands to hold pencil or pick up a coin/token...
You likely can't join if
- Subject has severe joint contractures that would affect ability to perform study measures, determined by the study physician.
- Subject has a deconditioned respiratory system, per the discretion of the physician investigator.
- Subject has behavioral or cognitive problems that preclude participation in the study, in the opinion of the investigator.
The study team makes the final eligibility decision.
Where it's taking place
- Kharkiv, Kharkiv Oblast, Ukraine
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kharkiv, Kharkiv Oblast, Ukraine. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.